Pharmicell Co., Ltd.
🇰🇷South Korea
Long-term Follow-up of Patients With Chronic Kidney Disease Who Had Administered Cellgram-CKD in PMC-P-12 Study
Active, not recruiting
- Conditions
- Renal Insufficiency, Chronic
- First Posted Date
- 2021-10-27
- Last Posted Date
- 2024-03-25
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT05096182
- Locations
- 🇰🇷
Asan Medical Center Hospital, Seoul, Korea, Republic of
Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
Not Applicable
Recruiting
- Conditions
- Alcoholic Cirrhosis
- Interventions
- Biological: Cellgram-LC
- First Posted Date
- 2021-10-26
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 100
- Registration Number
- NCT05093881
- Locations
- 🇰🇷
Gangwon National University Hospital, ChunCheon, Korea, Republic of
🇰🇷Hallym Univ. Medical Center, ChunCheon, Korea, Republic of
🇰🇷Gangneung Asan Hospital, Gangneung-si, Korea, Republic of
Clinical Trial to Evaluate Safety of Allogeneic Bone Marrow Derived Mesenchymal Stem Cell in Chronic Kidney Disease
Phase 1
Completed
- Conditions
- Chronic Kidney Disease stage4Chronic Kidney Disease Stage 3B
- Interventions
- Biological: Cellgram-CKD
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-03-22
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT05042206
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis
Phase 3
Recruiting
- Conditions
- Alcoholic Cirrhosis
- Interventions
- Biological: Cellgram-LC
- First Posted Date
- 2020-12-30
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT04689152
- Locations
- 🇰🇷
Hallym Univ. Medical Center, ChunCheon, Korea, Republic of
🇰🇷Soonchunhyang University Hospital, Seoul, Korea, Republic of
🇰🇷Gangwon National University Hospital, ChunCheon, Korea, Republic of
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC-PC)
Phase 1
Terminated
- Conditions
- Castration Resistant Prostate Cancer, CRPC
- Interventions
- Biological: Cellgram-DC-PC
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2023-01-03
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 3
- Registration Number
- NCT04615845
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)
Phase 1
Terminated
- Conditions
- Ovarian Cancer
- Interventions
- Biological: Cellgram-DC
- First Posted Date
- 2020-11-03
- Last Posted Date
- 2023-01-03
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 2
- Registration Number
- NCT04614051
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
Clinical Trial to Evaluate Efficacy and Safety of of Autologous Mesenchymal Stem Cells (MSC) Injected Intracavernously
Phase 2
Recruiting
- Conditions
- Erectile Dysfunction
- Interventions
- Biological: Cellgram-ED
- First Posted Date
- 2020-10-20
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 54
- Registration Number
- NCT04594850
- Locations
- 🇰🇷
Ewha womans university medical center, Seoul, Korea, Republic of
🇰🇷Asan medical center, Seoul, Korea, Republic of
🇰🇷Seoul ST. Mary's hospital, Seoul, Korea, Republic of
Follow up Study(Phase 1) to Evaluate Safety of Autologous Bone Marrow Derived MSCs in Erectile Dysfunction
- Conditions
- Erectile Dysfunction
- Interventions
- Other: no Intervention
- First Posted Date
- 2019-05-01
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03933995
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC
Phase 1
- Conditions
- Alcoholic Liver Cirrhosis
- Interventions
- Biological: Cellgram™ (Bone marrow-derived MSCs)
- First Posted Date
- 2019-02-12
- Last Posted Date
- 2020-10-22
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03838250
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Long-term Follow-up Study of Livercellgram in Alcoholic LC Patients Who Completed Livercellgram Phase 2 Study
Completed
- Conditions
- Alcoholic Liver Cirrhosis
- First Posted Date
- 2016-06-20
- Last Posted Date
- 2020-11-02
- Lead Sponsor
- Pharmicell Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02806011
- Locations
- 🇰🇷
Wonju Severance Christian Hospital, Wŏnju, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath